Company Details
  • Taizhou Volsen Chemical Co., Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Americas , Asia , East Europe , Europe , North Europe , Other Markets , West Europe , Worldwide
  • Exporter:91% - 100%
  • Certs:GS, CE, ISO9001, ISO14000
  • Description:Steroidogenesis Inhibitor Trilostane 13647-35-3,Trilostane Veterinary Medicine 13647-35-3,Trilostane Called As Vetoryl Cas 13647-35-3
Taizhou Volsen Chemical Co., Ltd. Steroidogenesis Inhibitor Trilostane 13647-35-3,Trilostane Veterinary Medicine 13647-35-3,Trilostane Called As Vetoryl Cas 13647-35-3
Home > Products > Active Pharmaceutical Ingredients > Trilostane For Cushing's Syndrome Treatment 13647-35-3

Trilostane For Cushing's Syndrome Treatment 13647-35-3

Share to:  
    Payment Type: L/C,T/T,D/P,D/A
    Min. Order: 1 Gram

Basic Info

Model No.: 13647-35-3

Additional Info

Productivity: Customized

Brand: VOLSENCHEM

Transportation: Ocean,Air

Place of Origin: CHINA

Supply Ability: COMMERCIAL

Product Description

Trilostane cas number 13647-35-3 is a new action mechanism of anti-estrogen new drugs, can reduce all endogenous steroids, including estrogen and androgen formation, since it was approved in the market,scholars have studied it for postmenopausal women late Breast cancer, and published a small report of the effective report. Then,after the expiration of the patent, BioEnvision company decided to further study trilostane. A series of clinical trials were conducted in postmenopausal women who were treated with tamoxifen has no response for progressive breast cancer women and registered in more than 780 patients in Europe, the United States and Australia. The results showed that trilostane has high activity on anticancer. Total effective rate was 42%, and the objective response rate to the hormone-sensitive subjects was as high as 55%, both of which were significantly better than the standard two-line drugs Enzyme inhibitors. In addition, older animals, especially older dogs, are susceptible to Cushing's syndrome, and trilostane cas 13647-35-3 can relieve symptoms of more than 90% of the dogs and improve their quality of life, so the drug is also approved in the UK.
Trilostane cas number 13647-35-3 itself has no hormonal activity, so its side effects are less, safety and tolerance are particularly good. Its safety is completely within the acceptable range, the main side effects are mild to moderate diarrhea and abdominal discomfort. However, trilostane can inhibit the production of adrenal hormones, so in the course of medication must be added corticosteroids, such as dexamethasone or hydrocortisone and so on.


Thera. Category: Anti-Cancer

Cas No.: 13647-35-3

Synonym: TRILOSTANE; androstane-2-carbonitrile,4,5-epoxy-17-hydroxy-3-oxo-,(2-alpha,4-alpha,5-al;modrenal

13647-35-3

Molecular Formula: C20H27NO3

Molecular Weight: 329.43

Pharmacopeia: in house spe.

Specifications:Available on request

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Looking for ideal Steroidogenesis Inhibitor Trilostane 13647-35-3 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Trilostane Veterinary Medicine 13647-35-3 are quality guaranteed. We are China Origin Factory of Trilostane Called As Vetoryl Cas 13647-35-3. If you have any question, please feel free to contact us.

Product Categories : Active Pharmaceutical Ingredients

Product Images
  • Trilostane For Cushing's Syndrome Treatment 13647-35-3
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2018 Taizhou Volsen Chemical Co., Ltd. All rights reserved.
Communicate with Supplier?Supplier
Amy Cheng Ms. Amy Cheng
What can I do for you?